Beta-cell preservation by incretin-based therapy

被引：0
|
作者：
Menge, B. A. [1 ]
机构：
[1] Ruhr Univ Bochum, Med Klin 1, St Josef Hosp, D-44791 Bochum, Germany
来源：
DIABETOLOGE | 2011年 / 7卷 / 05期
关键词：
Cell death; Cell division; Regeneration; Glucagon-like peptide 1; Diabetes mellitus; type; 2; GLUCAGON-LIKE PEPTIDE-1; INSULIN-SECRETION; DIABETIC-RATS; MASS; HUMANS; REPLICATION; APOPTOSIS; PANCREAS; EXENDIN-4; MECHANISM;
D O I：
10.1007/s11428-011-0700-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Preservation of pancreatic beta-cells in patients with type 2 diabetes would be a substantial therapeutic improvement as the disease is associated with a progressive loss of insulin-producing beta-cells. In various preclinical studies glucagon-like peptide 1 (GLP-1) led to preservation of beta-cell mass by inducing beta-cell proliferation and neogenesis as well as inhibiting apoptosis. These results cannot readily be translated to the situation in humans and further clinical evidence is needed.
引用
收藏
页码：316 / 320
页数：5
相关论文
共 50 条
  • [1] β-Zell-Erhalt durch inkretinbasierte TherapienFiktion oder Wirklichkeit?Beta-cell preservation by incretin-based therapyFiction or reality?
    B.A. Menge
    Der Diabetologe, 2011, 7 (5): : 316 - 320
  • [2] Incretin-based therapy and pancreatic beta cells
    Chon, S.
    Riveline, J. -P.
    Blondeau, B.
    Gautier, J. -F.
    DIABETES & METABOLISM, 2014, 40 (06) : 411 - 422
  • [3] Incretin research and incretin-based diabetes therapy
    Nauck, M. A.
    Seufert, J.
    DIABETOLOGE, 2017, 13 (07): : 474 - 474
  • [4] Incretin-based Therapy is on the Advance
    Meier, J. J.
    DIABETOLOGE, 2011, 7 (05): : 300 - 300
  • [5] Predicting response to incretin-based therapy
    Kalra, Sanjay
    Kalra, Bharti
    Sahay, Rakesh
    Agrawal, Navneet
    RESEARCH AND REPORTS IN ENDOCRINE DISORDERS, 2011, 1 : 11 - 19
  • [6] Socioeconomic aspects of incretin-based therapy
    Karagiannis, Thomas
    Bekiari, Eleni
    Tsapas, Apostolos
    DIABETOLOGIA, 2023, 66 (10) : 1859 - 1868
  • [7] Incretin-based therapy on diabetic nephropathy
    Yamada, Yuichiro
    Fujita, H.
    Takashima, S.
    Narita, T.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S19 - S20
  • [8] Incretin-based therapy: renal effects
    Korbut, A., I
    Klimontov, V. V.
    DIABETES MELLITUS, 2016, 19 (01): : 53 - 63
  • [9] Cardiovascular Response to Incretin-Based Therapy
    Jax, T.
    DIABETES STOFFWECHSEL UND HERZ, 2009, 18 (06): : 477 - 480
  • [10] Incretin-Based Therapy and the Quest for Sustained Improvements in β-Cell Health
    Drucker, Daniel J.
    DIABETES CARE, 2011, 34 (09) : 2133 - 2135
12345